Malignant hepatoma in the Bantu.
D002759:Adenoma, Bile Duct / Q000188:drug therapy* / Q000532:radiotherapy; D000351:Africa, Eastern; D000410:Alanine Transaminase / Q000097:blood; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D044383:Black People; D001798:Blood Proteins / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D004796:Clinical Enzyme Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013019:South Africa; D014750:Vincristine / Q000627:therapeutic use; D005719:gamma-Globulins / Q000032:analysis
D000970:Antineoplastic Agents; D001798:Blood Proteins; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D005719:gamma-Globulins; D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005472:Fluorouracil; D011241:Prednisone; D006918:Hydroxyurea; D008727:Methotrexate